Female genital neoplasms

PubMed Free Full Text

Cervical cancer: HPV testing

Africa

• PLoS ONE
  • Prevalence of Human Papillomavirus Genotypes among African Women with Normal Cervical Cytology and Neoplasia: A Systematic Review and Meta-Analysis [2015]

Americas

• Pan American Health Organization
  • Integrating HPV testing in cervical cancer screening program: a manual for program managers [2016]

Asia-Pacific

• JCO Global Oncology
  • Self-Collection Cervical Screening in the Asia-Pacific Region: A Scoping Review of Implementation Evidence [2023]

Australia

• Australian Family Physician
  • HPV testing in the National Cervical Screening Program – when is it recommended? [2013]

• Australian Journal of General Practice
  • Human papillomavirus testing as part of the renewed National Cervical Screening Program [2018]

• BMJ
  • National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study [2022]

Bahrain

• BMC Cancer
  • An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain [2014]

Bhutan

• BMC Infectious Diseases
  • Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme [2014]

Brazil

• Revista Brasileira de Ginecologia e Obstetrícia
  • Cervical Cancer Screening with HPV Testing: Updates on the Recommendation [2022]
  • Guidelines for HPV-DNA Testing for Cervical Cancer Screening in Brazil [2018]

Canada

• Canadian Agency for Drugs and Technologies in Health
  • Self-Sampling Devices for HPV Testing [2021]
  • HPV Testing for Primary Cervical Cancer Screening: Recommendations Report [2019]

• Canadian Family Physician
  • Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women [2017]

• Current Oncology
  • Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations [2023]
  • Are Canadian Women Prepared for the Transition to Primary HPV Testing in Cervical Screening? A National Survey of Knowledge, Attitudes, and Beliefs [2023]

• Public Health Agency of Canada
  • Human Papillomavirus (HPV)

China

• Archives of Gynecology and Obstetrics
  • Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis [2020]

• BMC Medicine
  • Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study [2021]

Croatia

• PLoS ONE
  • Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia [2017]

Denmark

• Cancer Medicine
  • Adherence to follow-up after the exit cervical cancer screening test at age 60-64: A nationwide register-based study [2022]

• Journal of Lower Genital Tract Disease
  • HPV Test as Test of Cure After Conization for CIN2+: A Nationwide Register-Based Cohort Study [2022]

• Obstetrics & Gynecology
  • Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years [2021]

• PLoS ONE
  • Histological outcomes in HPV-screened elderly women in Denmark [2021]

El Salvador

• International Journal of Cancer
  • The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador [2015]

• Journal of Lower Genital Tract Disease
  • Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador [2016]

Estonia

• JAMA Network Open
  • Prevaccination Prevalence of Type-Specific Human Papillomavirus Infection by Grade of Cervical Cytology in Estonia [2023]

Ethiopia

• Virology Journal
  • Human papillomavirus genotype distribution in Ethiopia: an updated systematic review [2022]

Europe

• Clinical Microbiology and Infection
  • Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans [2020]

• Life
  • Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening [2020]

Finland

• BMC Women's Health
  • The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland [2015]

Gulf Cooperation Council

• Cancer Cytopathology
  • Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology [2019]

High-income countries

• BMJ Sexual & Reproductive Health
  • Women's attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review [2022]

Hungary

• Pathology & Oncology Research
  • The Prevalence of High-Risk Human Papillomavirus in Hungary—A Geographically Representative, Cross-Sectional Study [2022]

India

• JCO Global Oncology
  • Challenges in the Implementation of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in India: A Systematic Review [2023]

International

• BMJ Global Health
  • HPV self-sampling for cervical cancer screening: a systematic review of values and preferences [2021]

• Cancer Prevention Research
  • A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus–positive and -Negative Cervical Precancers [2020]

• Clinical Microbiology and Infection
  • Commercially available molecular tests for human papillomaviruses: a global overview [2020]
  • Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? [2015]

• Diagnostic Cytopathology
  • Statement on HPV DNA Test Utilization [2009]

• International Journal of Cancer
  • Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older [2009]

• Journal of Gynecologic Oncology
  • Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis [2022]

• PLoS ONE
  • Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide [2014]

Ireland

• Health Information and Quality Authority
  • HTA of HPV testing for cervical cancer screening [2017]

Italy

• Epidemiologia e Prevenzione
  • hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi) [2015]
  • A first survey of HPV-based screening in routine cervical cancer screening in Italy [2015]

Japan

• Asian Pacific Journal of Cancer Prevention
  • Prevalence and Risk Factors of Human Papillomavirus Infection among Japanese Female People: A Nationwide Epidemiological Survey by Self-Sampling [2021]

Latin America

• PLoS ONE
  • Type-Specific HPV Prevalence in Cervical Cancer and High-Grade Lesions in Latin America and the Caribbean: Systematic Review and Meta-Analysis [2011]

Latin America, Sub-Saharan Africa

• Systematic Reviews
  • HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis [2023]

Low and middle income countries

• BMC Cancer
  • Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study [2017]

Middle East, North Africa

• Journal of Infection and Public Health
  • Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis [2020]

Montenegro

• Acta Clinica Croatica
  • HPV typing as a screening program for prevention and early detection of cervical cancer in different Montenegro regions [2020]

Netherlands

• BJOG: An International Journal of Obstetrics & Gynaecology
  • Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study [2021]

• International Journal of Cancer
  • Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening [2016]
  • Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended? [2014]

• Preventive Medicine
  • HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme [2019]

New Zealand

• PLoS ONE
  • Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand [2016]

Nigeria

• Asian Pacific Journal of Cancer Prevention
  • Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women: A Systematic Review and Meta-Analysis [2020]

• Journal of International Medical Research
  • High-risk human papillomavirus infection among Nigerian women: A systematic review and meta-analysis [2023]

Republic of Korea

• Journal of Gynecologic Oncology
  • High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology [2020]

Romania

• Annals of Global Health
  • HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions [2019]

Singapore

• Society for Colposcopy and Cervical Pathology of Singapore
  • SCCPS Scientific Committee Position Paper on Primary HPV Screening for Cervical Cancer Prevention [2016]

Slovenia

• Acta Dermatovenerologica Alpina, Pannonica et Adriatica
  • A review of 20 years of HPV research in Slovenia [2011]

Spain

• BMC Women's Health
  • Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain [2021]

Sub-Saharan Africa

• BMJ Open
  • Mapping evidence on the acceptability of human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review [2023]

• Frontiers in Public Health
  • Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection Among Sub-Saharan African Women: A Systematic Review and Meta-Analysis [2022]

• Gynecologic Oncology
  • Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis [2022]

• Implementation Science Communications
  • A systematic review of randomized control trials of HPV self-collection studies among women in sub-Saharan Africa using the RE-AIM framework [2021]

• Infectious Agents and Cancer
  • Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials [2021]

Sweden

• PLoS ONE
  • Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden [2020]

Turkey

• Asian Pacific Journal of Cancer Prevention
  • Analysis of the Prevalence and Quantification of Viral Load of Different Human Papillomavirus Types in Turkish Women Population [2022]

• Turkish Journal of Obstetrics and Gynecology
  • Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey [2021]

United Kingdom

• NHS England
  • Cervical screening: acceptable HPV tests

• Public Health England
  • Human papillomavirus (HPV): primary screening protocol
  • Cervical screening: primary HPV screening implementation
  • Cervical screening: pathway for acceptance of new HPV tests
  • Cervical screening: laboratory testing for human papillomavirus
  • Cervical screening: laboratory HPV testing and cytology services

• Public Health Scotland
  • Women's understanding of the introduction of HPV testing to the cervical screening programme in Scotland [2019]

United States

• Acta Cytologica
  • 2013 Statement on Human Papillomavirus DNA Test Utilization [2014]

• Agency for Healthcare Research and Quality
  • Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force [2018]

• American Cancer Society
  • The time has come to implement primary human papillomavirus screening for cervical cancer in the United States [2023]
  • Implementation in action: Collaborating on the transition to primary HPV screening for cervical cancer in the United States [2023]

• American Journal of Managed Care
  • The Budget Impact of Cervical Cancer Screening Using HPV Primary Screening [2016]

• American Society for Colposcopy and Cervical Pathology
  • A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines [2020]

• Cancer Cytopathology
  • Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration approval, clinical trials, and where we are today [2014]

• College of American Pathologists
  • Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey [2016]

• Journal of the National Cancer Institute
  • Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management [2022]

• Journal of Women's Health
  • The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis [2016]
  • Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening [2013]

• Preventive Medicine
  • Primary HPV testing recommendations of US providers, 2015 [2017]

• Society of Gynecologic Oncology
  • Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance [2015]
  • Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test  [2015]

WHO

• International Agency for Research on Cancer
  • Using HPV tests for cervical cancer screening and managing HPV-positive women – a practical online guide [2023]

• World Health Organization
  • WHO recommendations on self-care interventions: human papillomavirus (HPV) self-sampling as part of cervical cancer screening and treatment, 2022 update [2023]
  • WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV): web annex [2021]
  • WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV) [2021]
  • Introducing and scaling up testing for human papillomavirus as part of a comprehensive programme for prevention and control of cervical cancer [2020]
  • Human papillomavirus (HPV) self-sampling as part of cervical cancer screening [2020]
  • Human papillomavirus laboratory manual [2010]

{Related topics}

• Topic
  • Cervical cancer: screening, prevention
  • Cervical cancer